摘要
目的探讨双水平无创通气治疗慢性阻塞性肺病合并Ⅱ型呼吸衰竭的临床疗效。方法64例慢性阻塞性肺病合并Ⅱ型呼吸衰竭的患者,随机分为对照组和无创呼吸机治疗组。两组患者均给予氧疗、抗感染、祛痰、支气管扩张剂、糖皮质激素、呼吸兴奋剂、纠正水电解质酸碱失衡等常规治疗;无创呼吸机治疗组在上述常规治疗基础上加BiPAP无创呼吸机治疗。比较两组治疗前后动脉血气变化、插管率、两组患者治疗住院时间、总费用。结果两组患者治疗后动脉血气均较治疗前显著改善,而无创呼吸机治疗组治疗效果显著优于对照组,且住院时间、病死率、插管率均低于对照组。结论使用无创呼吸机可有效改善慢性阻塞性肺病合并Ⅱ型呼吸衰竭患者血气,可以降低患者因病情加重导致插管有创通气的风险,值得临床推广应用。
Objective To estimate the efficacy of noninvasive ventilation with Bi-level positive airway pressure model in the patients with type Ⅱ respiratory failure by COPD.Methods Sixty-four patients with type Ⅱ respiratory failure by COPD were divided into two groups at random.In routine drugs treated group(32 cases)oxygen therapy,anti-infection,eliminating phlegm,bronchodilators,gloucocorticoid and respiratory stimulant were used,in the noninvasive ventilation group(32 cases)were treated with noninvasive mechanical ventilation and routine drugs.The arterial blood gas,length of stay,cost and death rate,cannula rate were compared.Results After treatment the arterial blood gas was improved,but the noninvasive group was better(P0.05).And in this research,the length of stay,cost and death rate,cannula rate of noninvasive group were all lower than routine drug treated group(P0.05).Conclusion Noninvasive ventilation can improve the arterial blood gas,lower length of stay,cost and death rate,cannula rate efficiently in the patient with respiratory failure by COPD.Noninvasive ventilation is a valuable method in treatment of the patient with type Ⅱ respiratory failure by COPD.
出处
《四川医学》
CAS
2010年第4期483-485,共3页
Sichuan Medical Journal
关键词
慢性阻塞性肺疾病
无创通气
呼吸衰竭
respiratory failure
noninvasive ventilation
chronic obstructive pulmonary disease